Healthcare

The Commonwealth Bank has given Healthscope a $100 million lifeline as the embattled hospital giant appoints receivers to negotiate a sale.

Northwest Healthcare Properties REIT has promised to work with potential buyers as Healthscope -- the trust's second largest tenant -- collapses.

Medtech start-up Strongroom AI has lost its bid for a court order blessing its proposal to sell the company to SRSPV Pty Ltd prior to a second creditors meeting.

A class action has been filed against the State of Queensland on behalf of First Nations people alleging inadequate healthcare and substandard medical treatment.

A judge has refused an eleventh-hour application by administrators for Strongroom AI for court approval of a sale offer ahead of a second creditors meeting, likening the bid to “putting a gun to the court's head".

A judge has refused to stay a lease dispute between landlord Dexus and South Australia's premium medical research centre in favour of a contractual dispute resolution mechanism, saying it would be “unjust” to deprive Dexus of a court hearing.

Generic drug maker Sandoz wants to shield information turned up by preliminary discovery orders from the eyes of Amgen patent attorneys in a spat over cheap versions of Amgen's bone disease drugs, and says if they view the material they should be barred from prosecuting future related patents.

Biopharmaceutical company Amgen has lodged proceedings against generic maker Sandoz, calling for documents related to regulatory approval of a generic version of its top-selling bone disease treatments.

Drug giant Sanofi has failed in its appeal of a decision granting applications by biopharmaceutical company Amgen for patents covering the cholesterol-lowering treatment Repatha.

Real estate landlord Dexus is suing South Australia's medical research insitute for failing to execute on 30-year leases to occupy Adelaide's Australian Bragg Centre, despite "repeated demands".